Zepp Health Corp (ZEPP) stock
ZEPPNYSEElectronic ComputersFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 24, 2026Score 0/30
$2.60−0.01 (-0.38%)
Close on Nov 18, 2026Market cap $38.17MP/E –Yield –
Zepp Health r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2023 it was CN¥361.81M, down 30.0% from the year before. The highest annual figure on record is CN¥538.01M in fiscal 2020.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | CN¥361.81M | -30.0% |
| FY2022 | Dec 31, 2022 | CN¥517.12M | +0.4% |
| FY2021 | Dec 31, 2021 | CN¥515.08M | -4.3% |
| FY2020 | Dec 31, 2020 | CN¥538.01M | +24.9% |
| FY2019 | Dec 31, 2019 | CN¥430.82M | +63.7% |
| FY2018 | Dec 31, 2018 | CN¥263.22M | +71.1% |
| FY2017 | Dec 31, 2017 | CN¥153.83M | +16.3% |
| FY2016 | Dec 31, 2016 | CN¥132.30M | +114.9% |
| FY2015 | Dec 31, 2015 | CN¥61.55M | – |
See a number that looks wrong?